Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

You searched for:

Patients with complex medical needs, such as those with active autoimmune conditions, hepatitis B or C, and those receiving corticosteroids at baseline, may now receive these agents in the community. This raises important questions regarding safety, monitoring, and the likelihood of an anticancer response in these patients.
Updates in Small Cell lung cancer Abhirami Vivekanandarajah, MD Hematologist Oncologist New York Cancer and Blood Specialists Disclosure of Conflicts of Interest Abhirami Vivekanandarajah, MD, has the following financial relationships to disclose: •Speaker – Astra Zaneca •Consultant – Aptitude Small Cell Lung Cancer • SCLC accounts for ~ 13% of all lung …
Implementing a Quality Intervention for Patients with Clinical Characteristics of Advanced Polycythemia Vera A GUIDE FOR PHARMACY DIRECTORS AND CLINICAL PHARMACISTS Help your clinicians identify the subset of patients with clinical characteristics of advanced PV PV is a hematologic malignancy that may become advanced in a subset of patients despite treatment …
SO13-Highlights-of-ASCO-2013
Accelerated Approvals Reconsidered None Changes in Dosing/Administration None Changes in Labeled Indications Kyprolis® (carfilzomib) – FDA notified Amgen that its proteasome inhibitor—acquired as part of the company’s 2013 purchase of Onyx Pharmaceuticals—was approved for use in combination with Sarclisa® (isatuximab) and dexamethasone for the treatment of adult patients with …
Actor portrayal. Find LONSURF efficacy and safety information inside Please see additional Important Safety Information throughout and full Prescribing Information. Selected Important Safety Information Severe Myelosuppression: LONSURF caused severe and life-threatening myelosuppression (Grade 3-4) consisting of neutropenia (38%), anemia (18%), thrombocytopenia (5%), and febrile neutropenia …
CCMED_9_12_Infographic_Sep_18_2020 Staging and Testing for Stage III/IV Non-Small Cell Lung Cancer: Perspectives from Pathologists and Pulmonologists in US cancer care programs Improving pathologist and pulmonologist know-how on diagnostic modalities and alleviating barriers to care delivery can optimize care for stage III/IV NSCLC patients Accurate staging and testing using …
Figure10_PsychologicalHealthQuestionaire_PHQ-9.indd Patient Name: ____________________________________________________ Date: _____________________________ Over the last 2 weeks, how often have you been bothered by the following problems? NOT AT ALL 0 0 0 0 0 0 0 0 0 PHQ–9 – Psychological Health Questionnaire 1. Little interest or pleasure in doing …
Amgen-SafetyNetAttestationForm
Figure3_Katz_ActivityDailyLiving.indd Patient Name: ____________________________________________________ Date: _____________________________ Patient ID: ________________________________________________________ Activities Points (1 or 0) Independence: (1 Point) NO supervision, direction or personal assistance. Dependence: (0 Points) WITH supervision, direction, personal …
PowerPoint Presentation Planning for and Treating COVID+ Patients in Clinic Jenna VanGilder, MHA, RN, OCN, CENP Service Line Director Cancer Services & Palliative Care, Edward Elmhurst Health Friday, May 1, 2020 Situation – The COVID-19 Pandemic January 30 March 11 March 12 March 16 World Health Organization (WHO) declares COVID-19 a public emergency …
SO13-CME-CE-Opportunities
3/21/22, 3:49 PM AMCCBS > Sponsor Toolkit https://www.accc-cancer.org/home/attend/accc-48th-annual-meeting-cancer-center-business-summit/social-media-toolkit/sponsor-toolkit 1/3   Home / Attend / ACCC 48th Annual Meeting & Cancer Center Business Summit / Social Media Toolkit / Sponsor Toolkit Sponsor Toolkit We’ve created a few social media messages to get you started. Simply copy …
Eighth Annual Wisconsin Review of the San Antonio Breast Cancer Symposium Saturday, January 28, 2023 The Pfister Hotel, Milwaukee Agenda 7:00 AM Registration Open, Networking Breakfast in Resource Center 7:50 AM Welcome & Introductions Benjamin M. Parsons, DO President, Wisconsin Association of Hematology and Oncology Session I Moderator: Sailaja Kamaraju, MD, MS, Medical …
1 Association of Community Cancer Centers Increase Referrals for Smoking Cessation Problem Statement Root Causes Patients with advanced lung cancer are not receiving referrals for smoking cessation • Patients may not express interest in smoking cessation • Lack of awareness about local smoking cessation resources • Oncologists may be reluctant to refer patients …
000644_018_SCLC_BRFMDay1Ltr_lo7 • Atezolizumab (TECENTRIQ) + carboplatin/etoposide is a Category 1 preferred immunotherapy/chemotherapy option for first-line treatment of patients with ES-SCLC in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®)1*†‡ *Category 1: Based upon high-level evidence, there is uniform NCCN consensus that the intervention is appropriate. …
AVASTIN Hepatocellular Carcinoma (HCC) SAMPLE CODING Hepatocellular Carcinoma (HCC) TYPE CODE DESCRIPTION Diagnosis: ICD-10-CM C22.0 Liver cell carcinoma, hepatocellular carcinoma C22.8 Malignant neoplasm of liver, primary, unspecified as to type Drug: HCPCS J9035 Injection, bevacizumab, 10 mg Drug: NDC Note: Payer requirements regarding use of a 10-digit or 11-digit …
All Together Now for Inclusive Cancer Trials (Stand up to Cancer, LUNGevity Foundation, Moffitt Cancer Center and Platform Q) Stand Up to Cancer Resources Toolkit #InclusionPledge for Black Women,Tigerlily Foundation #KnowMoreDisparities and #PullUpASeat Bi-Directional Conversation Series, Tigerlily Foundation Carrying Equity in COVID-19 Vaccination Forward: Guidance Informed by Communities …
In this special podcast episode, we talk with oncology social worker and ACCC President Krista Nelson, MSW, LCSW, OSW-C, FAOSW, about finding opportunities to practice gratitude each day for colleagues and patients.
Molecular-Testing-Biopsy-Samples-Insufficient-for-Molecular-Testing